Callan JMB Inc. Stock Price, News & Analysis

Callan JMB (NASDAQ: CJMB), a logistics company specializing in healthcare and emergency management, reported its full year 2024 financial results. The company successfully completed its IPO on February 6, 2025, raising approximately $5.7 million at $4.00 per share.

Key financial metrics for 2024 include:

• Total revenue: $6.6 million ($3.8M from emergency response, $2.8M from specialty packaging)
• Gross profit: $2.6 million with 39.1% margin
• Operating loss: $2.3 million
• Net loss: $2.3 million

Notable achievements include extending arrangements with Texas DSHS, securing a five-year contract with Oregon Health Authority, launching a vaccine management lease program, and joining Complete Group Services. Revenue was impacted by reduced emergency preparedness services post-COVID and a temporary suspension of orders from one customer.

Callan JMB (NASDAQ: CJMB), a healthcare and emergency management logistics services provider, has announced its participation in two major investor conferences in March 2025.

The company will present at the Sidoti Spring Small-Cap Conference (March 19-20, virtual) with CEO Wayne Williams speaking on March 19th at 10:45 a.m. ET. Additionally, they will participate in the iAcccess Alpha Virtual Best Ideas Spring Investment Conference (March 25-26) with a presentation on March 25th at 10:30 a.m. ET.

Management will conduct one-on-one investor meetings during both conferences. Interested parties can schedule meetings through Sidoti or iAccess Alpha representatives, or by contacting KCSA Strategic Communications.

Callan JMB (NASDAQ: CJMB) has been requested by the Texas Department of Health and Human Services to be on standby for the recent measles outbreak response. The company holds a five-year contingency contract awarded in 2023 for receiving, storing, and distributing medical countermeasures for public health emergencies.

The company is proactively submitting a 30-day roster of 24/7 available personnel to handle distribution requests. This follows their successful track record from their first emergency response contract in 2018, which was activated during the COVID-19 and MPOX pandemic, where they managed the storage and distribution of over 2 million vaccines and therapeutics.

The current measles outbreak has claimed one life, and Callan JMB is preparing to support the state's emergency response with their expert staff, equipped facilities, and quality-controlled inventory management system.

Callan JMB (NASDAQ: CJMB) has launched an innovative lease program for immunization management infrastructure, targeting government agencies and private organizations. The program offers comprehensive vaccine management solutions without requiring substantial upfront equipment investments.

The lease package includes refrigerators, freezers, ultra-cold units, generators, computer equipment, and mobile clinic kits, all monitored by their proprietary Sentry system. This solution helps organizations avoid investing approximately $100,000 in equipment purchases.

The company's track record includes managing 2.27 million COVID-19 vaccine doses, 32.2 million testing supplies, and 113,401 COVID-19 therapeutics for Texas Department of State Health Services from April 2020 through January 2024. Callan JMB operates vaccine management centers in Texas, Oregon, and Illinois.

Callan JMB (NASDAQ: CJMB) announced successful immunization administration across 44 Tennessee counties through its partnership with Health Hero Tennessee. Since early 2023, the company has provided logistics support, specialized equipment, and regulatory compliance oversight for voluntary vaccination clinics at schools and community events.

The program focuses on underprivileged communities, offering free immunizations to uninsured individuals with parental consent. Callan JMB installed cold storage units, computer equipment, and its Sentry temperature monitoring system, providing real-time monitoring and backup generators. The facility mirrors similar operations in Oregon, Chicago, and Texas.

The company's model, inspired by its Texas backup facility for emergency medical supply storage, can be adapted for other state and local governments and healthcare organizations establishing community response centers or rural emergency medical response units.

Callan JMB (NASDAQ: CJMB) has secured a second five-year contract with the Oregon Health Authority (OHA) for medical emergency preparedness and response services. This renewal follows the company's successful operations during COVID-19 and MPOX pandemics, where they handled over 800,000 vaccines across 75,000 miles in Oregon.

The new contract involves storing and managing medical countermeasures for threat assessments and event response missions in Oregon. During COVID-19, Callan JMB's operations reduced vaccine distribution points from 15 to 1 while improving accessibility in rural and remote areas, including tribal health centers. The company serves Oregon's population of 4.2 million through secure, federally compliant, and reliable logistics expertise.

Callan JMB (NASDAQ: CJMB) announced that underwriters have partially exercised their over-allotment option from its initial public offering, issuing an additional 163,569 shares at $4.00 per share, generating additional gross proceeds of $654,276.

Following this partial exercise, the total IPO has reached 1,443,569 shares with aggregate net proceeds of approximately $4.73 million after deducting underwriting discounts, commissions, and offering expenses. Alexander Capital served as the managing underwriter and sole book runner, with Paulson Investment Company and Bancroft Capital as co-managers.

Callan JMB (NASDAQ: CJMB) has successfully completed its initial public offering (IPO), raising approximately $5.12 million in gross proceeds through the sale of 1,280,000 shares of common stock at $4.00 per share. The company's shares began trading on the Nasdaq Capital Market on February 5, 2025, under the ticker symbol 'CJMB'.

The company, which specializes in healthcare logistics and emergency management services, has granted underwriters a 45-day option to purchase up to an additional 192,000 shares. The net proceeds will be used for sales support, marketing, customer expansion and general corporate purposes, including working capital. Alexander Capital served as the managing underwriter and sole book runner, with Paulson Investment Company and Bancroft Capital acting as co-managers.

Callan JMB (NASDAQ: CJMB) has announced the pricing of its initial public offering of 1,280,000 shares at $4.00 per share, aiming to raise approximately $5.12 million in gross proceeds before deducting underwriting costs and offering expenses.

The company has granted underwriters a 45-day option to purchase up to an additional 192,000 shares at the public offering price. Trading is expected to begin on the Nasdaq Capital Market on February 5, 2025, under the ticker symbol 'CJMB', with the offering closing around February 6, 2025.

The net proceeds will be used for sales support, marketing, customer expansion, and general corporate purposes, including working capital. Alexander Capital is serving as the managing underwriter, with Paulson Investment Company as joint book-runner.